[Worsening for using statin in carnitine palmityol transferase deficiency myopathy].
作者信息
Delgado-López F, Bautista-Lorite J, Villamil-Fernández F
机构信息
Servicio de Neurología, Unidad de Neuromuscular, Hospital Virgen del Rocío, Sevilla.
出版信息
Rev Neurol. 2004;38(11):1095.
PMID:15202093
Abstract
摘要
相似文献
1
[Worsening for using statin in carnitine palmityol transferase deficiency myopathy].
Rev Neurol. 2004;38(11):1095.
2
Genetic predisposition to statin myopathy.
Curr Opin Rheumatol. 2008 Nov;20(6):648-55. doi: 10.1097/BOR.0b013e328314b7b4.
3
Statin myopathy: a review of recent progress.
Curr Opin Rheumatol. 2010 Nov;22(6):644-50. doi: 10.1097/BOR.0b013e32833f0fc7.
4
Myopathy associated with statin therapy.
Neuromuscul Disord. 2008 Jan;18(1):97-8. doi: 10.1016/j.nmd.2007.08.008. Epub 2007 Sep 24.
5
Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Muscle Nerve. 2006 Aug;34(2):153-62. doi: 10.1002/mus.20567.
6
Statin-associated myopathy and its exacerbation with exercise.
Muscle Nerve. 2010 Oct;42(4):469-79. doi: 10.1002/mus.21817.
7
8
Noninvasive evaluation of adult onset myopathy from carnitine palmitoyl transferase II deficiency using proton magnetic resonance spectroscopy.
J Rheumatol. 1999 Aug;26(8):1757-63.
9
Mitochondrial alterations in muscle biopsies of patients on statin therapy.
J Submicrosc Cytol Pathol. 2004 Jan;36(1):85-9.
10
Statin-Associated Autoimmune Myopathy.
N Engl J Med. 2016 Feb 18;374(7):664-9. doi: 10.1056/NEJMra1515161.
Zotero 插件